Grid Oasis
S&P 500NASDAQ 100Dow JonesRussell 2000All StocksSectors & Industries

ROIV

+ Watchlist+ Portfolio

Roivant Sciences Ltd.

Regulated industryPhysical productsTags from an AI model reading the company description.
GridBrain

GridBrain — Sign in

GridSentinel

GridSentinel — Sign in

GridAegis

GridAegis — Sign in

Key Metrics

Previous Close
$38.71
52-Week Range
$19.96 – $42.50
Market Cap
$28.06B
P/E (TTM)
—
EPS (TTM)
-0.65
Dividend Yield
0.00%
Advanced Metrics
Price/Book
6.97
PEG Ratio
—
Return on Equity
-8.54%
Return on Assets
-16.50%
Gross Margin
0.00%
Operating Margin
-3226.26%
Profit Margin
0.00%
Current Ratio
15.56
Debt/Equity
0.02
Total Debt
$106.57M
Free Cash Flow
$-358.86M
Revenue Growth
2135.60%
Earnings Growth
—
Enterprise Value
$24.54B

Market Snapshot

About

Roivant Sciences is a biopharmaceutical company focused on applying technology and data science to drug development. The company builds subsidiary biotech and healthcare technology companies (Vants) to develop and commercialize medicines and technologies. Roivant aims to improve the efficiency and success rate of bringing innovative therapies to patients through its unique organizational model.